Suppr超能文献

[2012年法国免费补充医疗保险覆盖人群的医疗保健利用情况]

[Health care use by free complementary health insurance coverage beneficiaries in France in 2012].

作者信息

Tuppin P, Samson S, Colinot N, Gastaldi-Menager C, Fagot-Campagna A, Gissot C

机构信息

Département des études sur les pathologies et les patients (DEPP), Caisse nationale d'assurance maladie des travailleurs salariés, 26-50, avenue du Professeur-André-Lemierre, 75986 Paris cedex 20, France.

Département des études sur les pathologies et les patients (DEPP), Caisse nationale d'assurance maladie des travailleurs salariés, 26-50, avenue du Professeur-André-Lemierre, 75986 Paris cedex 20, France.

出版信息

Rev Epidemiol Sante Publique. 2016 Apr;64(2):67-78. doi: 10.1016/j.respe.2015.12.015. Epub 2016 Feb 23.

Abstract

BACKGROUND

The objective was to investigate healthcare use among people covered by one of the two complementary healthcare insurance schemes available for people with low annual income: CMUC (universal complementary healthcare insurance) and, for people whose income exceeds the CMUC ceiling, ACS (aid for complementary healthcare insurance). Comparisons were made between CMUC and ACS beneficiaries versus CMUC and ACS non-beneficiaries and between CMUC beneficiaries and ACS beneficiaries.

METHODS

Using the national health insurance information system (SNIIRAM), people less than 60 years old covered by the general national health insurance (86% of the 66 million inhabitants) and with ACS or CMUC coverage in 2012 were selected. Diseases were identified using hospital diagnosis, drugs refunds and long-term chronic disease status. Hospital related diagnoses were categorized in major hospital activity groups. Sex- and age-standardized relative risk (RR) were calculated.

RESULTS

There were 4.4 million (9.6%) CMUC beneficiaries and 732,000 (1.6%) ACS beneficiaries (56% and 54% women; mean age: 24 years and 29 years respectively versus 52% and 30 years for CMUC or ACS non-beneficiaries). CMUC or ACS beneficiaries had more often cardiovascular diseases (RR=1.4;2.1) and diabetes (RR=2.2;2.4). Their sex- and age-standardized hospitalisation rates for all diagnosis were higher (18%; 17%, RR=1.3;1.4) than CMUC or ACS non-beneficiaries (13%). This was especially the case for the following major groups: toxicology, intoxications, alcohol major group (RR=3.8;4.0); psychiatry (RR=2.8;4.1); respiratory disease (RR=1.9;2.3); infectious disease (RR=1.9;2.7). Compared with CMUC beneficiaries, ACS beneficiaries had more often cancer (RR=1.5), cardiovascular disease (RR=1.5), neurological disease (RR=2.7), psychiatric illness (RR=2.6), end-stage renal disease (RR=2.8), hemophilia (RR=1.4) or cystic fibrosis (RR=1.6) and they received also more often disability allowance (20%, 4%).

CONCLUSION

The disease and hospitalisation rates of ACS beneficiaries are similar or higher than those of CMUC beneficiaries, especially for disabling diseases. Both CMUC and ACS beneficiaries received healthcare for chronic diseases that can be targeted by prevention and screening programs for more optimal healthcare.

摘要

背景

目的是调查年收入较低人群可享有的两种补充医疗保险计划之一覆盖人群的医疗保健使用情况:CMUC(全民补充医疗保险),以及收入超过CMUC上限人群的ACS(补充医疗保险援助)。对CMUC和ACS受益人与CMUC和ACS非受益人之间以及CMUC受益人与ACS受益人之间进行了比较。

方法

利用国家健康保险信息系统(SNIIRAM),选取2012年参加国家基本医疗保险(6600万居民中的86%)且年龄小于60岁、有ACS或CMUC覆盖的人群。通过医院诊断、药品报销和长期慢性病状况来确定疾病。医院相关诊断被归类到主要医院活动组。计算性别和年龄标准化相对风险(RR)。

结果

有440万(9.6%)CMUC受益人以及73.2万(1.6%)ACS受益人(女性分别占56%和54%;平均年龄分别为24岁和29岁,而CMUC或ACS非受益人中女性分别占52%和30岁)。CMUC或ACS受益人更常患有心血管疾病(RR = 1.4;2.1)和糖尿病(RR = 2.2;2.4)。他们所有诊断的性别和年龄标准化住院率(18%;17%,RR = 1.3;1.4)高于CMUC或ACS非受益人(13%)。在以下主要组中尤其如此:毒理学、中毒、酒精主要组(RR = 3.8;4.0);精神病学(RR = 2.8;4.1);呼吸系统疾病(RR = 1.9;2.3);传染病(RR = 1.9;2.7)。与CMUC受益人相比,ACS受益人更常患有癌症(RR = 1.5)、心血管疾病(RR = 1.5)、神经系统疾病(RR = 2.7)、精神疾病(RR = 2.6)、终末期肾病(RR = 2.8)、血友病(RR = 1.4)或囊性纤维化(RR = 1.6),并且他们也更常领取残疾津贴(20%,4%)。

结论

ACS受益人的疾病和住院率与CMUC受益人相似或更高,尤其是对于致残性疾病。CMUC和ACS受益人都接受了针对慢性病的医疗保健,这些慢性病可通过预防和筛查计划来更优化医疗保健。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验